Skip to main content
Premium Trial:

Request an Annual Quote

Biocept Prices $7.5M Public Offering of Stocks, Warrants

NEW YORK (GenomeWeb) – Biocept today priced its public offering of 6.25 million shares of its common stock and warrants to purchase up to 6.25 million shares of the common stock.

Each share of stock is being sold with one warrant to purchase one share of common stock at a combined price of $1.20 per share and warrant. Gross proceeds from the offering are expected to be about $7.5 million.

The warrants, Biocept said, will be exercisable at $1.20 per share and will expire five years from the date of issuance. The offering is expected to close on or about Feb. 12. Maxim Group is the book-running manager and Dawson James Securities is the co-manager on the offering.

Biocept has granted the underwriter a 45-day option to purchase an additional 937,500 shares of common stock and/or warrants to purchase up to 937,500 shares of common stock at $1.20 per share.

The San Diego-based company said in a document filed with the US Securities and Exchange Commission that it intended to offer about 3.6 million shares of its common stock and warrants to purchase another 3.6 million shares of common stock at about $2.11 per share and warrant for net proceeds of about $6.8 million, or $7.8 million if the underwriter exercised its option in full.

Biocept said in its document that proceeds would go toward general corporate purposes and ongoing operations, as well as expansion of the business.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.